RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.
about
Role of lipotoxicity in endothelial dysfunctionInteraction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanismsNa, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly.New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy.Schisandrin B Ameliorates ICV-Infused Amyloid β Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression.Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury.The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in miceGeneOptimizer program-assisted cDNA reengineering enhances sRAGE autologous expression in Chinese hamster ovary cells.Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?Activation of mTOR: a culprit of Alzheimer's disease?Neuroprotective effect of β-asarone against Alzheimer's disease: regulation of synaptic plasticity by increased expression of SYP and GluR1Accumulation of minor alleles and risk prediction in schizophreniaRAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.AGE-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression.The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis.Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.
P2860
Q27000731-9BE5AF2A-E461-4E69-9113-C6C3804C2F38Q27001177-82D902E9-0D1F-489F-AFA1-312F1D351801Q28572007-3DAA7E3B-F5F2-4699-A499-8BC350347EEEQ34368970-303800B0-91C3-465D-A5E9-C8AD9AB93902Q35838027-C41F6990-7774-4DE7-BD36-02E8C66B99ECQ36179583-31EF3F1D-EC08-4E2E-8AAA-8435400307CBQ36800611-94086A82-9F95-4879-8045-EF641669339CQ37607192-B1394816-FBD6-4B1B-A21C-ECBFC8BB86A8Q38283308-8D808CE0-7776-487B-9D40-50895FABC7AFQ38443497-A755EB47-2A12-4EE7-99CC-8878C0DCB52BQ38773315-22B70A07-B4AA-4C3C-87F2-2B6F23430855Q41718177-7AC5027E-74DA-4843-A604-09B771818333Q47867340-C93445F0-50E0-4DFB-A0BE-664BBB54AD95Q48129676-E9E06CFA-F23A-4307-B0B1-BCF7CCF415D1Q48332393-72865EED-1C08-4B73-ADEB-3BC7BCA51FF5Q49256155-5954C9CB-0E72-4621-985A-45F0C63B9BD5
P2860
RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.
@en
type
label
RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.
@en
prefLabel
RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.
@en
P2093
P2860
P356
P1476
RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.
@en
P2093
Doris Chen
John Xi Chen
Shiqian Yan
Shirley ShiDu Yan
P2860
P304
P356
10.2741/265
P577
2012-01-01T00:00:00Z